A detailed history of Lynch Asset Management, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Lynch Asset Management, Inc. holds 106,300 shares of NVO stock, worth $11.2 Million. This represents 5.33% of its overall portfolio holdings.

Number of Shares
106,300
Previous 104,800 1.43%
Holding current value
$11.2 Million
Previous $15 Million 15.39%
% of portfolio
5.33%
Previous 6.39%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$119.07 - $145.42 $178,605 - $218,129
1,500 Added 1.43%
106,300 $12.7 Million
Q2 2024

Jul 22, 2024

SELL
$122.71 - $146.91 $245,420 - $293,820
-2,000 Reduced 1.87%
104,800 $15 Million
Q3 2023

Oct 25, 2023

BUY
$90.94 - $199.54 $4.86 Million - $10.7 Million
53,400 Added 100.0%
106,800 $9.71 Million
Q4 2021

Feb 02, 2022

BUY
$95.88 - $117.08 $5.12 Million - $6.25 Million
53,400 New
53,400 $5.98 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $238B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Lynch Asset Management, Inc. Portfolio

Follow Lynch Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lynch Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Lynch Asset Management, Inc. with notifications on news.